<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cetuximab is an epidermal growth factor receptor inhibitor used in <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e>, and <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Several cutaneous side effects due to cetuximab such as <z:hpo ids='HP_0001061'>acne</z:hpo>-like <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e>, <z:hpo ids='HP_0000989'>pruritus</z:hpo>, <z:hpo ids='HP_0000958'>dry skin</z:hpo>, desquamation, <z:hpo ids='HP_0000998'>hypertrichosis</z:hpo>, and <z:hpo ids='HP_0001818'>paronychia</z:hpo> have been reported so far </plain></SENT>
<SENT sid="2" pm="."><plain>A 59-year-old male patient with metastatic <z:hpo ids='HP_0003003'>colon cancer</z:hpo> referred to our outpatient clinic for his lesions on the dorsal surfaces of his hands and wrists, and on thighs developing after the chemotherapy </plain></SENT>
<SENT sid="3" pm="."><plain>He was diagnosed as neutrophilic eccrine <z:e sem="disease" ids="C0085160" disease_type="Disease or Syndrome" abbrv="">hydradenitis</z:e> related to cetuximab in the light of clinical and histopathological findings </plain></SENT>
<SENT sid="4" pm="."><plain>According to our knowledge, this is the first reported case of neutrophilic ecrine <z:e sem="disease" ids="C0085160" disease_type="Disease or Syndrome" abbrv="">hydradenitis</z:e> due to cetuximab </plain></SENT>
</text></document>